A Rare Case of Small Cell Lung Cancer With an Epidermal Growth Factor Receptor Mutation and Its Response to Osimertinib

Small cell lung cancer (SCLC) accounts for less than 15% of the cases of lung cancer. Epidermal growth factor receptor (EGFR) mutations are rarely reported in association with SCLC. EGFR tyrosine kinase inhibitors (TKI) are approved as the first-line therapy for metastatic non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhuiyan, Sakil, Siddiqui, Raheel S, Zirkiyeva, Milana, Agladze, Mariam, Bashir, Tayyaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214366/
https://www.ncbi.nlm.nih.gov/pubmed/34164239
http://dx.doi.org/10.7759/cureus.15136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214366/
https://www.ncbi.nlm.nih.gov/pubmed/34164239
http://dx.doi.org/10.7759/cureus.15136

Ejemplares similares